Laboratorio Varifarma – Argentina
A strategic pharmaceutical partner with deep specialization in oncology, hematology and complex therapies.
Advancing access to advanced treatments since 1995
Varifarma is an Argentine pharmaceutical company established in 1995, with a strong focus on oncology, hematology, onco-hematology, rare diseases and other complex therapies.
The company describes its mission around developing and producing high-quality medicines and improving access to advanced treatments. Varifarma has developed an extensive portfolio and international presence, spanning oncology, hematology, onco-hematology, rare diseases, transplant, genomic testing, hospital and specialty care, among other areas.
Why Varifarma
- Long-standing pharmaceutical heritage dating to 1995
- Strong specialization in oncology and complex therapies
- Portfolio across oncology, hematology and rare diseases
- Experience with international licensing and strategic partnerships
- International product registrations and Latin American presence
- Focus on quality, research, development and continuous improvement
Therapeutic coverage
- Oncology
- Onco-hematology
- Hematology
- Rare diseases
- Transplant
- Genomic testing
- Specialty and hospital care
Oncology & onco-hematology agents
Varifarma’s public portfolio includes products and therapies across oncology and onco-hematology, including:
- Carboplatin
- Docetaxel
- Cabazitaxel
- Capecitabine
- Irinotecan
- Targeted therapies
- Other specialty medicines
Varifarma is a strategic pharmaceutical partner of Uniphar Pakistan. Not every Varifarma product is available in every Uniphar market — product availability, licensing rights, registration status and territory rights are confirmed market by market. Individual products remain subject to regulatory approval, licensing and commercial arrangements in each territory.
Explore a Partnership
Let’s build the next generation of specialty pharmaceutical opportunities together.